A detailed history of Optivise Advisory Services LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Optivise Advisory Services LLC holds 1,374 shares of ABBV stock, worth $233,071. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,374
Holding current value
$233,071
% of portfolio
0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $225,116 - $273,879
1,374 New
1,374 $271 Million
Q2 2024

Nov 14, 2024

BUY
$154.79 - $180.76 $128,940 - $150,573
833 Added 60.63%
2,207 $378 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Optivise Advisory Services LLC Portfolio

Follow Optivise Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optivise Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Optivise Advisory Services LLC with notifications on news.